[Skip to Content]
[Skip to Content Landing]
December 17, 2003

Acarbose for Patients With Hypertension and Impaired Glucose Tolerance—Reply

Author Affiliations

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290(23):3066. doi:10.1001/jama.290.23.3066-a

To the Editor: Dr Chiasson and colleagues1 reported that treatment with acarbose was associated with a significant reduction in the incidence of cardiovascular disease and hypertension among patients with impaired glucose tolerance (IGT). The authors claimed that their study was the first to report these results. In fact, however, my colleagues and I have previously reported that acarbose and glibenclamide significantly reduced blood pressure levels among patients with hypertension and type 2 diabetes.2